B

BeOne

Global oncology therapeutics discovery, development, manufacturing

Associate Director - Global Value & Access, Hematology

Corporate StrategyConfirmed live in the last 24 hours
Full-time$153.1k - $203.1k /yr

About the Job

Requirements

  • A bachelor's degree in life sciences, health economics, pharmacy, health policy, business, or a related field is required.
  • At least 8 years of biopharmaceutical experience, with a substantial portion in global, regional, or country value, access, pricing, and reimbursement roles.
  • Demonstrated expertise in health technology assessment processes and payer systems across key markets, including G-BA/IQWiG, NICE, HAS, and the US payer environment; IRA/MFN awareness is a plus.
  • Experience building global value dossiers, health technology assessment and EU Joint Clinical Assessment submission content, and payer value evidence in partnership with health economics and outcomes research.
  • Working knowledge of global or major-market pricing strategy, international reference pricing/reference-pricing management, and price/revenue scenario modeling for specialty or oncology/hematology products.
  • Strong understanding of pivotal-trial evidence interpretation and comparator/competitive assessment in oncology or hematology.
  • Proven ability to lead cross-functional and cross-regional initiatives and influence without direct authority in a matrixed, global organization.
  • Excellent written and verbal communication skills in English.

Responsibilities

  • Develop and help lead the global market access and reimbursement strategy across lead and potential future pipeline indications, aligned to pivotal evidence and relevant comparators.
  • Support development of global value, access, and pricing inputs for asset lifecycle planning, indication sequencing, and evidence prioritization to maximize long-term access, reimbursement, and portfolio value; provide input to governance and oversight bodies as delegated.
  • Translate regional and affiliate payer insights into actionable recommendations for clinical development, evidence generation, pricing, access strategy, and commercialization planning.
  • Collaborate cross-functionally to integrate access and payer requirements into development, influencing trial design, endpoints, and evidence generation to meet payer needs.
  • Build country-ready access toolkits in partnership with health economics and outcomes research, including global value dossiers, budget-impact and cost-effectiveness frameworks, and payer communication materials aligned to pivotal evidence and comparators.
  • Support EU Joint Clinical Assessment strategy and dossier development with health economics and outcomes research, Joint Clinical Assessment coordinators, and the wider cross-functional team.
  • Track access milestones, evidence needs, and deliverables against the launch plan, and flag risks and dependencies to the Director.
  • Serve as a day-to-day point of contact for regional and affiliate teams on access and pricing deliverables, fulfill requests, share materials, and train teams on the toolkits.
  • Coordinate and align deliverables across Pricing, health economics and outcomes research, Medical Affairs, Regulatory, Commercial, and Clinical Development.
  • Feed affiliate and payer insights back to the Director to inform strategy and evidence decisions.
  • Monitor the competitive, pricing, health technology assessment, and policy landscape, including BTK-class dynamics and EU health technology assessment/Joint Clinical Assessment developments, and translate changes into actionable updates to strategy and toolkits.

Desired Qualifications

  • Postgraduate science degree (PhD, PharmD, or MD) and/or MBA; advanced degrees such as MSc, MPH, PharmD, PhD, or MBA are strongly preferred.
  • In-country, regional, or affiliate market access, pricing, reimbursement, or health technology assessment experience, with direct exposure to payer decision-making and reimbursement processes.
  • Oncology/hematology launch experience, ideally including EU Joint Clinical Assessment launches.
  • Health economics and outcomes research fluency in budget-impact and cost-effectiveness modeling sufficient to partner effectively and quality-check deliverables.

About the Company

BeOne

Global oncology therapeutics discovery, development, manufacturing

BeOne Medicines discovers, develops, and commercializes oncology therapies worldwide, focusing on hematologic cancers and solid tumors. Its products work by leveraging internal R&D and clinical development to bring therapies to market quickly, with Brukinsa serving as a leading backbone in the US and European markets. It differentiates itself through a large-scale global clinical network and cost-efficient development and manufacturing that support high margins and a focus on large-market cancer indications. Its goal is to expand access to high-impact, affordable cancer treatments across more than 45 countries while growing its pipeline into immunology and solid tumors.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Dongcheng District, China
Founded
2010

Recently Posted Jobs

Explore more opportunities at BeOne

See more jobs